FDA Approved: BEXAROTENE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bexarotene from ANI Pharmaceuticals, updating the labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

SUPPL AP for BEXAROTENE (BEXAROTENE)